nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—atherosclerosis	0.262	1	CbGaD
Prasugrel—ALB—Rosuvastatin—atherosclerosis	0.0703	0.137	CbGbCtD
Prasugrel—CYP2B6—Simvastatin—atherosclerosis	0.0667	0.13	CbGbCtD
Prasugrel—CYP2C19—Rosuvastatin—atherosclerosis	0.0456	0.0888	CbGbCtD
Prasugrel—CYP2C19—Simvastatin—atherosclerosis	0.0424	0.0826	CbGbCtD
Prasugrel—CYP2C19—Lovastatin—atherosclerosis	0.0415	0.0808	CbGbCtD
Prasugrel—CYP2C9—Rosuvastatin—atherosclerosis	0.0379	0.0739	CbGbCtD
Prasugrel—CYP2C9—Simvastatin—atherosclerosis	0.0352	0.0687	CbGbCtD
Prasugrel—CYP2C9—Pravastatin—atherosclerosis	0.0345	0.0672	CbGbCtD
Prasugrel—CYP2C9—Lovastatin—atherosclerosis	0.0345	0.0672	CbGbCtD
Prasugrel—CYP3A4—Rosuvastatin—atherosclerosis	0.022	0.0429	CbGbCtD
Prasugrel—CYP3A4—Ezetimibe—atherosclerosis	0.022	0.0429	CbGbCtD
Prasugrel—CYP3A4—Simvastatin—atherosclerosis	0.0205	0.0399	CbGbCtD
Prasugrel—CYP3A4—Lovastatin—atherosclerosis	0.0201	0.0391	CbGbCtD
Prasugrel—CYP3A4—Pravastatin—atherosclerosis	0.0201	0.0391	CbGbCtD
Prasugrel—Haemoptysis—Niacin—atherosclerosis	0.00191	0.0299	CcSEcCtD
Prasugrel—Neoplasm malignant—Ezetimibe—atherosclerosis	0.00189	0.0296	CcSEcCtD
Prasugrel—Pain in extremity—Lovastatin—atherosclerosis	0.00119	0.0187	CcSEcCtD
Prasugrel—Atrial fibrillation—Simvastatin—atherosclerosis	0.00118	0.0185	CcSEcCtD
Prasugrel—Pain in extremity—Ezetimibe—atherosclerosis	0.00117	0.0183	CcSEcCtD
Prasugrel—Atrial fibrillation—Niacin—atherosclerosis	0.00108	0.0169	CcSEcCtD
Prasugrel—Haematuria—Rosuvastatin—atherosclerosis	0.00104	0.0162	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00103	0.0161	CcSEcCtD
Prasugrel—Oedema peripheral—Ezetimibe—atherosclerosis	0.000798	0.0125	CcSEcCtD
Prasugrel—Angioedema—Rosuvastatin—atherosclerosis	0.000776	0.0121	CcSEcCtD
Prasugrel—Cough—Rosuvastatin—atherosclerosis	0.000741	0.0116	CcSEcCtD
Prasugrel—Angiopathy—Ezetimibe—atherosclerosis	0.000735	0.0115	CcSEcCtD
Prasugrel—Immune system disorder—Ezetimibe—atherosclerosis	0.000732	0.0115	CcSEcCtD
Prasugrel—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00073	0.0114	CcSEcCtD
Prasugrel—Haemoglobin—Niacin—atherosclerosis	0.000713	0.0112	CcSEcCtD
Prasugrel—Haemorrhage—Niacin—atherosclerosis	0.00071	0.0111	CcSEcCtD
Prasugrel—Oedema peripheral—Niacin—atherosclerosis	0.000699	0.0109	CcSEcCtD
Prasugrel—Back pain—Lovastatin—atherosclerosis	0.000696	0.0109	CcSEcCtD
Prasugrel—Back pain—Ezetimibe—atherosclerosis	0.000682	0.0107	CcSEcCtD
Prasugrel—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000678	0.0106	CcSEcCtD
Prasugrel—Eye disorder—Niacin—atherosclerosis	0.000663	0.0104	CcSEcCtD
Prasugrel—Angioedema—Lovastatin—atherosclerosis	0.000657	0.0103	CcSEcCtD
Prasugrel—Anaemia—Ezetimibe—atherosclerosis	0.000652	0.0102	CcSEcCtD
Prasugrel—Angioedema—Ezetimibe—atherosclerosis	0.000645	0.0101	CcSEcCtD
Prasugrel—Angiopathy—Niacin—atherosclerosis	0.000644	0.0101	CcSEcCtD
Prasugrel—Leukopenia—Lovastatin—atherosclerosis	0.000644	0.0101	CcSEcCtD
Prasugrel—Anaemia—Simvastatin—atherosclerosis	0.000622	0.00973	CcSEcCtD
Prasugrel—Cough—Ezetimibe—atherosclerosis	0.000616	0.00964	CcSEcCtD
Prasugrel—Angioedema—Simvastatin—atherosclerosis	0.000615	0.00962	CcSEcCtD
Prasugrel—Hypertension—Ezetimibe—atherosclerosis	0.000609	0.00953	CcSEcCtD
Prasugrel—Leukopenia—Simvastatin—atherosclerosis	0.000602	0.00943	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000597	0.00934	CcSEcCtD
Prasugrel—Anaphylactic shock—Lovastatin—atherosclerosis	0.000587	0.00919	CcSEcCtD
Prasugrel—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000576	0.00901	CcSEcCtD
Prasugrel—Thrombocytopenia—Lovastatin—atherosclerosis	0.000575	0.009	CcSEcCtD
Prasugrel—Angioedema—Niacin—atherosclerosis	0.000565	0.00883	CcSEcCtD
Prasugrel—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000564	0.00882	CcSEcCtD
Prasugrel—Anaemia—Pravastatin—atherosclerosis	0.000562	0.0088	CcSEcCtD
Prasugrel—Skin disorder—Ezetimibe—atherosclerosis	0.000559	0.00875	CcSEcCtD
Prasugrel—Angioedema—Pravastatin—atherosclerosis	0.000556	0.0087	CcSEcCtD
Prasugrel—Leukopenia—Niacin—atherosclerosis	0.000553	0.00865	CcSEcCtD
Prasugrel—Anaphylactic shock—Simvastatin—atherosclerosis	0.000549	0.00859	CcSEcCtD
Prasugrel—Leukopenia—Pravastatin—atherosclerosis	0.000544	0.00852	CcSEcCtD
Prasugrel—Cough—Niacin—atherosclerosis	0.000539	0.00844	CcSEcCtD
Prasugrel—Thrombocytopenia—Simvastatin—atherosclerosis	0.000538	0.00841	CcSEcCtD
Prasugrel—Cough—Pravastatin—atherosclerosis	0.000531	0.00831	CcSEcCtD
Prasugrel—Hypertension—Pravastatin—atherosclerosis	0.000525	0.00822	CcSEcCtD
Prasugrel—Dyspnoea—Lovastatin—atherosclerosis	0.000523	0.00819	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000522	0.00818	CcSEcCtD
Prasugrel—Dyspnoea—Ezetimibe—atherosclerosis	0.000513	0.00803	CcSEcCtD
Prasugrel—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00051	0.00799	CcSEcCtD
Prasugrel—Fatigue—Lovastatin—atherosclerosis	0.000506	0.00792	CcSEcCtD
Prasugrel—Anaphylactic shock—Niacin—atherosclerosis	0.000504	0.00789	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000497	0.00778	CcSEcCtD
Prasugrel—Asthenia—Rosuvastatin—atherosclerosis	0.000497	0.00778	CcSEcCtD
Prasugrel—Anaphylactic shock—Pravastatin—atherosclerosis	0.000496	0.00777	CcSEcCtD
Prasugrel—Fatigue—Ezetimibe—atherosclerosis	0.000496	0.00777	CcSEcCtD
Prasugrel—Skin disorder—Niacin—atherosclerosis	0.00049	0.00766	CcSEcCtD
Prasugrel—Dyspnoea—Simvastatin—atherosclerosis	0.00049	0.00766	CcSEcCtD
Prasugrel—Thrombocytopenia—Pravastatin—atherosclerosis	0.000486	0.00761	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000474	0.00742	CcSEcCtD
Prasugrel—Diarrhoea—Rosuvastatin—atherosclerosis	0.000474	0.00742	CcSEcCtD
Prasugrel—Fatigue—Simvastatin—atherosclerosis	0.000473	0.00741	CcSEcCtD
Prasugrel—Hypotension—Niacin—atherosclerosis	0.000471	0.00737	CcSEcCtD
Prasugrel—Body temperature increased—Lovastatin—atherosclerosis	0.000464	0.00726	CcSEcCtD
Prasugrel—Dizziness—Rosuvastatin—atherosclerosis	0.000458	0.00717	CcSEcCtD
Prasugrel—Body temperature increased—Ezetimibe—atherosclerosis	0.000455	0.00712	CcSEcCtD
Prasugrel—Dyspnoea—Niacin—atherosclerosis	0.00045	0.00704	CcSEcCtD
Prasugrel—Dyspnoea—Pravastatin—atherosclerosis	0.000443	0.00693	CcSEcCtD
Prasugrel—Rash—Rosuvastatin—atherosclerosis	0.000437	0.00684	CcSEcCtD
Prasugrel—Dermatitis—Rosuvastatin—atherosclerosis	0.000436	0.00683	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Niacin—atherosclerosis	0.000435	0.00681	CcSEcCtD
Prasugrel—Body temperature increased—Simvastatin—atherosclerosis	0.000434	0.00679	CcSEcCtD
Prasugrel—Headache—Rosuvastatin—atherosclerosis	0.000434	0.00679	CcSEcCtD
Prasugrel—Hypersensitivity—Lovastatin—atherosclerosis	0.000433	0.00677	CcSEcCtD
Prasugrel—Fatigue—Pravastatin—atherosclerosis	0.000428	0.0067	CcSEcCtD
Prasugrel—Hypersensitivity—Ezetimibe—atherosclerosis	0.000424	0.00664	CcSEcCtD
Prasugrel—Asthenia—Lovastatin—atherosclerosis	0.000421	0.00659	CcSEcCtD
Prasugrel—Asthenia—Ezetimibe—atherosclerosis	0.000413	0.00647	CcSEcCtD
Prasugrel—Nausea—Rosuvastatin—atherosclerosis	0.000411	0.00644	CcSEcCtD
Prasugrel—Hypersensitivity—Simvastatin—atherosclerosis	0.000405	0.00633	CcSEcCtD
Prasugrel—Diarrhoea—Lovastatin—atherosclerosis	0.000402	0.00629	CcSEcCtD
Prasugrel—Body temperature increased—Niacin—atherosclerosis	0.000399	0.00624	CcSEcCtD
Prasugrel—Asthenia—Simvastatin—atherosclerosis	0.000394	0.00617	CcSEcCtD
Prasugrel—Diarrhoea—Ezetimibe—atherosclerosis	0.000394	0.00617	CcSEcCtD
Prasugrel—Body temperature increased—Pravastatin—atherosclerosis	0.000392	0.00614	CcSEcCtD
Prasugrel—Dizziness—Lovastatin—atherosclerosis	0.000388	0.00608	CcSEcCtD
Prasugrel—Dizziness—Ezetimibe—atherosclerosis	0.000381	0.00596	CcSEcCtD
Prasugrel—Diarrhoea—Simvastatin—atherosclerosis	0.000376	0.00588	CcSEcCtD
Prasugrel—Hypersensitivity—Niacin—atherosclerosis	0.000371	0.00581	CcSEcCtD
Prasugrel—Rash—Lovastatin—atherosclerosis	0.00037	0.00579	CcSEcCtD
Prasugrel—Dermatitis—Lovastatin—atherosclerosis	0.00037	0.00579	CcSEcCtD
Prasugrel—Headache—Lovastatin—atherosclerosis	0.000368	0.00576	CcSEcCtD
Prasugrel—Hypersensitivity—Pravastatin—atherosclerosis	0.000366	0.00572	CcSEcCtD
Prasugrel—Dizziness—Simvastatin—atherosclerosis	0.000363	0.00568	CcSEcCtD
Prasugrel—Rash—Ezetimibe—atherosclerosis	0.000363	0.00568	CcSEcCtD
Prasugrel—Dermatitis—Ezetimibe—atherosclerosis	0.000363	0.00568	CcSEcCtD
Prasugrel—Asthenia—Niacin—atherosclerosis	0.000362	0.00566	CcSEcCtD
Prasugrel—Headache—Ezetimibe—atherosclerosis	0.000361	0.00565	CcSEcCtD
Prasugrel—Asthenia—Pravastatin—atherosclerosis	0.000356	0.00557	CcSEcCtD
Prasugrel—Nausea—Lovastatin—atherosclerosis	0.000349	0.00546	CcSEcCtD
Prasugrel—Rash—Simvastatin—atherosclerosis	0.000346	0.00542	CcSEcCtD
Prasugrel—Dermatitis—Simvastatin—atherosclerosis	0.000346	0.00541	CcSEcCtD
Prasugrel—Diarrhoea—Niacin—atherosclerosis	0.000345	0.0054	CcSEcCtD
Prasugrel—Headache—Simvastatin—atherosclerosis	0.000344	0.00538	CcSEcCtD
Prasugrel—Nausea—Ezetimibe—atherosclerosis	0.000342	0.00535	CcSEcCtD
Prasugrel—Diarrhoea—Pravastatin—atherosclerosis	0.00034	0.00532	CcSEcCtD
Prasugrel—Dizziness—Niacin—atherosclerosis	0.000333	0.00522	CcSEcCtD
Prasugrel—Dizziness—Pravastatin—atherosclerosis	0.000328	0.00514	CcSEcCtD
Prasugrel—Nausea—Simvastatin—atherosclerosis	0.000326	0.0051	CcSEcCtD
Prasugrel—Rash—Niacin—atherosclerosis	0.000318	0.00498	CcSEcCtD
Prasugrel—Dermatitis—Niacin—atherosclerosis	0.000318	0.00497	CcSEcCtD
Prasugrel—Headache—Niacin—atherosclerosis	0.000316	0.00494	CcSEcCtD
Prasugrel—Rash—Pravastatin—atherosclerosis	0.000313	0.0049	CcSEcCtD
Prasugrel—Dermatitis—Pravastatin—atherosclerosis	0.000313	0.00489	CcSEcCtD
Prasugrel—Headache—Pravastatin—atherosclerosis	0.000311	0.00487	CcSEcCtD
Prasugrel—Nausea—Niacin—atherosclerosis	0.000299	0.00469	CcSEcCtD
Prasugrel—Nausea—Pravastatin—atherosclerosis	0.000295	0.00462	CcSEcCtD
Prasugrel—ALB—Metabolism—ABCG5—atherosclerosis	1.64e-05	0.000102	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.63e-05	0.000102	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOS3—atherosclerosis	1.62e-05	0.000101	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.62e-05	0.000101	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—FABP4—atherosclerosis	1.6e-05	0.0001	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LCAT—atherosclerosis	1.6e-05	0.0001	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LPA—atherosclerosis	1.58e-05	9.85e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOA4—atherosclerosis	1.57e-05	9.82e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CAV1—atherosclerosis	1.57e-05	9.78e-05	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.57e-05	9.78e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP27A1—atherosclerosis	1.57e-05	9.78e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—APOA1—atherosclerosis	1.57e-05	9.76e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.55e-05	9.65e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.54e-05	9.63e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BGN—atherosclerosis	1.53e-05	9.54e-05	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.52e-05	9.49e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.52e-05	9.47e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOA5—atherosclerosis	1.51e-05	9.45e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.51e-05	9.39e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NAMPT—atherosclerosis	1.5e-05	9.36e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—F2—atherosclerosis	1.49e-05	9.31e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—LIPC—atherosclerosis	1.49e-05	9.3e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALOX15—atherosclerosis	1.49e-05	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOA2—atherosclerosis	1.49e-05	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	1.49e-05	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	1.49e-05	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOC3—atherosclerosis	1.48e-05	9.24e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS2—atherosclerosis	1.48e-05	9.2e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.47e-05	9.19e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—LDLR—atherosclerosis	1.47e-05	9.18e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.47e-05	9.17e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.47e-05	9.16e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.47e-05	9.15e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PLA2G1B—atherosclerosis	1.46e-05	9.09e-05	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.44e-05	9.01e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.44e-05	8.99e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CETP—atherosclerosis	1.44e-05	8.97e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL8—atherosclerosis	1.44e-05	8.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.43e-05	8.92e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CG—atherosclerosis	1.43e-05	8.91e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.43e-05	8.91e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.43e-05	8.89e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.42e-05	8.88e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.42e-05	8.88e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LPA—atherosclerosis	1.42e-05	8.84e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALOX5—atherosclerosis	1.41e-05	8.78e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.41e-05	8.78e-05	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—AKT1—atherosclerosis	1.39e-05	8.66e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.38e-05	8.59e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BGN—atherosclerosis	1.37e-05	8.57e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.37e-05	8.56e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—atherosclerosis	1.37e-05	8.52e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.36e-05	8.5e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOA5—atherosclerosis	1.36e-05	8.48e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.36e-05	8.45e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.36e-05	8.45e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.36e-05	8.45e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOA2—atherosclerosis	1.36e-05	8.45e-05	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.35e-05	8.45e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.34e-05	8.35e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.34e-05	8.34e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.32e-05	8.24e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.31e-05	8.16e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IGF1—atherosclerosis	1.31e-05	8.16e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.3e-05	8.11e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.3e-05	8.11e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—atherosclerosis	1.3e-05	8.11e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.29e-05	8.07e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LPA—atherosclerosis	1.29e-05	8.06e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NFKB1—atherosclerosis	1.29e-05	8.02e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.28e-05	8e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.28e-05	7.98e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK8—atherosclerosis	1.26e-05	7.88e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.26e-05	7.88e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NAMPT—atherosclerosis	1.26e-05	7.88e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—atherosclerosis	1.26e-05	7.86e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.26e-05	7.83e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LIPC—atherosclerosis	1.26e-05	7.83e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BGN—atherosclerosis	1.25e-05	7.81e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOC3—atherosclerosis	1.25e-05	7.78e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.24e-05	7.75e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SERPINE1—atherosclerosis	1.24e-05	7.75e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOA5—atherosclerosis	1.24e-05	7.73e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LDLR—atherosclerosis	1.24e-05	7.73e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CETP—atherosclerosis	1.21e-05	7.55e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.2e-05	7.51e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.19e-05	7.44e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS3—atherosclerosis	1.19e-05	7.4e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.18e-05	7.36e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.17e-05	7.29e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.17e-05	7.28e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—atherosclerosis	1.17e-05	7.28e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.17e-05	7.27e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SCARB1—atherosclerosis	1.16e-05	7.23e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.16e-05	7.23e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—STAT3—atherosclerosis	1.16e-05	7.21e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.15e-05	7.19e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.13e-05	7.07e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.13e-05	7.03e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LIPC—atherosclerosis	1.13e-05	7.03e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.13e-05	7.02e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOC3—atherosclerosis	1.12e-05	6.98e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LDLR—atherosclerosis	1.11e-05	6.94e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK3—atherosclerosis	1.1e-05	6.89e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMGCR—atherosclerosis	1.1e-05	6.83e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CETP—atherosclerosis	1.09e-05	6.78e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—atherosclerosis	1.07e-05	6.68e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.06e-05	6.64e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LCAT—atherosclerosis	1.06e-05	6.6e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—FABP4—atherosclerosis	1.06e-05	6.6e-05	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.06e-05	6.6e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.04e-05	6.49e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOA4—atherosclerosis	1.04e-05	6.48e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.03e-05	6.45e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.03e-05	6.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LIPC—atherosclerosis	1.03e-05	6.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOC3—atherosclerosis	1.02e-05	6.37e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.02e-05	6.36e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LDLR—atherosclerosis	1.01e-05	6.33e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.01e-05	6.32e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMOX1—atherosclerosis	9.95e-06	6.2e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CETP—atherosclerosis	9.91e-06	6.18e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.88e-06	6.16e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMGCR—atherosclerosis	9.83e-06	6.13e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCA1—atherosclerosis	9.76e-06	6.09e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOB—atherosclerosis	9.53e-06	5.94e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SCARB1—atherosclerosis	9.49e-06	5.92e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.43e-06	5.88e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—atherosclerosis	9.27e-06	5.78e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.24e-06	5.76e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—LPL—atherosclerosis	9.1e-06	5.67e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMGCR—atherosclerosis	8.96e-06	5.59e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOA2—atherosclerosis	8.94e-06	5.57e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.94e-06	5.57e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.94e-06	5.57e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.94e-06	5.57e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPX1—atherosclerosis	8.88e-06	5.54e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.87e-06	5.53e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.83e-06	5.51e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCA1—atherosclerosis	8.76e-06	5.46e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CD36—atherosclerosis	8.65e-06	5.39e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—atherosclerosis	8.55e-06	5.33e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LPA—atherosclerosis	8.53e-06	5.32e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMOX1—atherosclerosis	8.37e-06	5.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BGN—atherosclerosis	8.26e-06	5.15e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—MTHFR—atherosclerosis	8.19e-06	5.11e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOA5—atherosclerosis	8.18e-06	5.1e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.09e-06	5.04e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK3—atherosclerosis	8.08e-06	5.04e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—atherosclerosis	8.07e-06	5.03e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARA—atherosclerosis	8.04e-06	5.01e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOB—atherosclerosis	8.02e-06	5e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCA1—atherosclerosis	7.99e-06	4.98e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.87e-06	4.91e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—atherosclerosis	7.84e-06	4.89e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—atherosclerosis	7.8e-06	4.87e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AGT—atherosclerosis	7.78e-06	4.85e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LPL—atherosclerosis	7.66e-06	4.78e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOE—atherosclerosis	7.63e-06	4.76e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.6e-06	4.74e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAV1—atherosclerosis	7.56e-06	4.71e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOA1—atherosclerosis	7.54e-06	4.7e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMOX1—atherosclerosis	7.52e-06	4.69e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPX1—atherosclerosis	7.47e-06	4.66e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—atherosclerosis	7.45e-06	4.64e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CD36—atherosclerosis	7.28e-06	4.54e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOB—atherosclerosis	7.2e-06	4.49e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—atherosclerosis	7e-06	4.37e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—MTHFR—atherosclerosis	6.9e-06	4.3e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CG—atherosclerosis	6.88e-06	4.29e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LPL—atherosclerosis	6.88e-06	4.29e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMOX1—atherosclerosis	6.85e-06	4.27e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.82e-06	4.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LIPC—atherosclerosis	6.78e-06	4.22e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARA—atherosclerosis	6.77e-06	4.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOC3—atherosclerosis	6.73e-06	4.2e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPX1—atherosclerosis	6.71e-06	4.18e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LDLR—atherosclerosis	6.69e-06	4.17e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—atherosclerosis	6.64e-06	4.14e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOB—atherosclerosis	6.57e-06	4.09e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AGT—atherosclerosis	6.55e-06	4.09e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CETP—atherosclerosis	6.54e-06	4.08e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CD36—atherosclerosis	6.53e-06	4.07e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—INS—atherosclerosis	6.52e-06	4.06e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOE—atherosclerosis	6.42e-06	4e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.39e-06	3.98e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAV1—atherosclerosis	6.36e-06	3.97e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOA1—atherosclerosis	6.35e-06	3.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LPL—atherosclerosis	6.27e-06	3.91e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.26e-06	3.9e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.19e-06	3.86e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPX1—atherosclerosis	6.12e-06	3.81e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARA—atherosclerosis	6.07e-06	3.79e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—atherosclerosis	5.97e-06	3.72e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CD36—atherosclerosis	5.96e-06	3.71e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.91e-06	3.69e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AGT—atherosclerosis	5.88e-06	3.67e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CG—atherosclerosis	5.79e-06	3.61e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOE—atherosclerosis	5.76e-06	3.59e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NOS3—atherosclerosis	5.71e-06	3.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAV1—atherosclerosis	5.71e-06	3.56e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOA1—atherosclerosis	5.7e-06	3.55e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.64e-06	3.52e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—atherosclerosis	5.59e-06	3.49e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARA—atherosclerosis	5.54e-06	3.45e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—INS—atherosclerosis	5.48e-06	3.42e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—atherosclerosis	5.45e-06	3.4e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AGT—atherosclerosis	5.36e-06	3.34e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.27e-06	3.29e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOE—atherosclerosis	5.25e-06	3.28e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.23e-06	3.26e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAV1—atherosclerosis	5.21e-06	3.25e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.2e-06	3.24e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOA1—atherosclerosis	5.19e-06	3.24e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—atherosclerosis	5.02e-06	3.13e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—INS—atherosclerosis	4.92e-06	3.07e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NOS3—atherosclerosis	4.81e-06	3e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.74e-06	2.96e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—atherosclerosis	4.58e-06	2.85e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.52e-06	2.82e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—atherosclerosis	4.51e-06	2.81e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—INS—atherosclerosis	4.49e-06	2.8e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—atherosclerosis	4.4e-06	2.74e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOB—atherosclerosis	4.33e-06	2.7e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NOS3—atherosclerosis	4.32e-06	2.69e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.21e-06	2.63e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LPL—atherosclerosis	4.13e-06	2.58e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—atherosclerosis	4.12e-06	2.57e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPX1—atherosclerosis	4.03e-06	2.52e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.95e-06	2.46e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NOS3—atherosclerosis	3.94e-06	2.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CD36—atherosclerosis	3.93e-06	2.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.72e-06	2.32e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARA—atherosclerosis	3.65e-06	2.28e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.6e-06	2.25e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AGT—atherosclerosis	3.54e-06	2.21e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOE—atherosclerosis	3.47e-06	2.16e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAV1—atherosclerosis	3.43e-06	2.14e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOA1—atherosclerosis	3.43e-06	2.14e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.13e-06	1.95e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—atherosclerosis	3.02e-06	1.88e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—INS—atherosclerosis	2.96e-06	1.85e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—atherosclerosis	2.71e-06	1.69e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—atherosclerosis	2.63e-06	1.64e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NOS3—atherosclerosis	2.6e-06	1.62e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.37e-06	1.48e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—atherosclerosis	2.21e-06	1.38e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—atherosclerosis	1.98e-06	1.24e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—atherosclerosis	1.81e-06	1.13e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—atherosclerosis	1.19e-06	7.44e-06	CbGpPWpGaD
